Skip to main content
Nephrology Dialysis Transplantation logoLink to Nephrology Dialysis Transplantation
. 2022 Feb 10;37(4):805. doi: 10.1093/ndt/gfab349

Erratum to: Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES)

Jonathan Barratt 1, Branislav Andric 2, Avtandil Tataradze 3, Michael Schömig 4, Michael Reusch 5, Udaya Valluri 6, Christophe Mariat 7
PMCID: PMC8951194  PMID: 35146511

In the originally published version of this manuscript, there was an error in the labelling of Figure 5A. The y-axis should read “Ferritin (ng/mL)” instead of “Ferritin (ng/L)”. This error has now been corrected online.

Contributor Information

Jonathan Barratt, Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.

Branislav Andric, Health Center Krusevac, Krusevac, Serbia.

Avtandil Tataradze, National Center of Urology, Tbilisi, Georgia.

Michael Schömig, Dialysis Center Heilbronn, Heilbronn, Germany.

Michael Reusch, Astellas Pharma Europe B.V., Leiden, The Netherlands.

Udaya Valluri, Astellas Pharma Global Development, Inc., Northbrook, IL, USA.

Christophe Mariat, CHU St Etienne, Service Nephrologie Dialyse Transplantation, St Etienne, France.


Articles from Nephrology Dialysis Transplantation are provided here courtesy of Oxford University Press

RESOURCES